NYSE
Veradermics, Incorporated (MANE)
♥ 343 Thanks from members
Veradermics, Incorporated (NYSE: MANE) exhibits highly favorable market and clinical sentiment driven by positive Phase 2/3 trials for its lead oral hair loss candidate, VDPHL01, backed by robust liquidity following an upsized IPO.